Pitcairn CO 10x Genomics, Inc. Transaction History

Pitcairn CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$36.08 - $54.3 $45,424 - $68,363	-1,259 Reduced 18.23%	5,648 $211,000
Q4 2023 Feb 14, 2024	SELL	$34.32 - $57.55 $22,513 - $37,752	-656 Reduced 8.67%	6,907 $386,000
Q3 2023 Nov 13, 2023	SELL	$40.86 - $62.98 $53,853 - $83,007	-1,318 Reduced 14.84%	7,563 $311,000
Q2 2023 Aug 11, 2023	BUY	$50.96 - $58.72 $68,388 - $78,802	1,342 Added 17.8%	8,881 $495,000
Q1 2023 May 05, 2023	BUY	$35.33 - $55.79 $67,056 - $105,889	1,898 Added 33.65%	7,539 $420,000
Q4 2022 Feb 13, 2023	BUY	$24.4 - $41.3 $137,640 - $232,973	5,641 New	5,641 $205,000
Q2 2022 Aug 12, 2022	BUY	$36.95 - $82.41 $61,078 - $136,223	1,653 Added 42.89%	5,507 $249,000
Q1 2022 May 12, 2022	BUY	$55.7 - $145.79 $138,136 - $361,559	2,480 Added 180.49%	3,854 $293,000
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $185,558 - $250,878	1,374 New	1,374 $205,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.